HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High aromatase expression in uterine leiomyoma tissues of African-American women.

AbstractCONTEXT:
Symptomatic uterine leiomyoma is associated with irregular uterine bleeding, anemia, and recurrent pregnancy loss. African-American women develop uterine leiomyomas at an earlier age and with higher frequency compared with Caucasian-American women or other races; however, the underlying mechanism for this discrepancy is unknown.
OBJECTIVE:
Our objective was to determine whether gene targets of emerging leiomyoma therapeutics such as aromatase inhibitors and antiprogestins, which reduce tumor size and symptoms, are differentially expressed in tissues of African-American (n = 31), Caucasian-American (n = 34), and Japanese women (n = 36).
RESULTS:
We found strikingly higher aromatase mRNA levels in leiomyoma compared with adjacent myometrium in African-American (83 fold), Caucasian-American (38 fold), and Japanese women (33 fold). Among the four major promoters that regulate aromatase expression in leiomyoma, the proximal promoter II accounted for higher aromatase mRNA levels in tissues from African-American women. Estrogen receptor subtype alpha mRNA levels were significantly, and 1.8- to 2.6-fold, higher in leiomyoma compared with adjacent myometrium in all groups, whereas leiomyoma estrogen receptor subtype beta mRNA levels were significantly elevated only in Japanese women. Leiomyoma progesterone receptor mRNA levels were significantly higher in Japanese women compared with African-American or Caucasian-American women.
CONCLUSIONS:
Leiomyoma tissues from African-American women contained the highest level of aromatase expression, which may result in elevated tissue concentrations of estrogen, and account for the higher prevalence and earlier incidence. Analysis of leiomyoma tissue for biomarkers may predict the response to hormonal treatments such as aromatase inhibitors.
AuthorsHiroshi Ishikawa, Scott Reierstad, Masashi Demura, Alfred W Rademaker, Tadayuki Kasai, Masaki Inoue, Hirokazu Usui, Makio Shozu, Serdar E Bulun
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 94 Issue 5 Pg. 1752-6 (May 2009) ISSN: 1945-7197 [Electronic] United States
PMID19240151 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Aromatase Inhibitors
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Progestins
  • RNA, Messenger
  • Receptors, Progesterone
  • Aromatase
Topics
  • Adult
  • Black or African American
  • Aromatase (biosynthesis, genetics)
  • Aromatase Inhibitors (therapeutic use)
  • Asian People
  • Estrogen Receptor alpha (biosynthesis, genetics)
  • Estrogen Receptor beta (biosynthesis, genetics)
  • Female
  • Humans
  • Leiomyoma (enzymology, genetics)
  • Middle Aged
  • Progestins (antagonists & inhibitors)
  • Promoter Regions, Genetic (genetics)
  • RNA, Messenger (biosynthesis, genetics)
  • Receptors, Progesterone (biosynthesis, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Uterine Neoplasms (enzymology, genetics)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: